Gilead Sciences GILD Balance Sheet

Income Statement

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	67.95B	63.08B	62.87B	62.56B	63.17B	61.88B	62.34B	62.37B
Total Current Assets	14.77B	12.63B	13.18B	13.55B	14.44B	13.46B	14.29B	15.98B
Cash and Equivalents	5.34B	4.3B	4.74B	4.7B	5.41B	4.94B	5.7B	5.71B
Total Non-Current Assets	58.3B	50.45B	49.7B	54.35B	54.2B	48.42B	48.05B	46.39B
Total Liabilities	46.89B	43.17B	42.66B	41.5B	41.96B	40.94B	41.24B	40.13B
Total Current Liabilities	11.61B	8.56B	9.22B	10.42B	11.24B	10.53B	13.96B	11.95B
Total Non-Current Liabilities	60.46B	59.79B	58.63B	54.03B	53.68B	53.37B	48.49B	51.38B
Common Equity	1M	1M	1M	1M	1M	1M	1M	1M
Retained Earnings	16.32B	14.99B	15.12B	15.76B	15.69B	15.22B	15.14B	16B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	56.98B	70.28B	63.68B	61.63B	68.41B	67.95B	63.17B	62.13B
Total Current Assets	20.45B	31.82B	35.84B	30.3B	16B	14.77B	14.44B	16.09B
Cash and Equivalents	8.23B	7.59B	17.94B	11.63B	6B	5.34B	5.41B	6.09B
Total Non-Current Assets	19.36B	20.5B	21.53B	22.65B	18.22B	21.06B	21.21B	22.75B
Total Liabilities	37.61B	49.78B	42.14B	38.98B	50.19B	46.89B	41.96B	39.38B
Total Current Liabilities	9.22B	11.64B	10.61B	9.76B	11.4B	11.61B	11.24B	11.28B
Total Non-Current Liabilities	54.74B	68.94B	56.11B	51.31B	67.43B	60.46B	53.68B	51.29B
Total Equity	19.36B	20.5B	21.53B	22.65B	18.22B	21.06B	21.21B	22.75B
Common Equity	1M	1M	1M	1M	1M	1M	1M	1M
Retained Earnings	18.15B	19.01B	19.02B	19.39B	14.38B	16.32B	15.69B	16.3B